Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
2 Vietnamese arrested for receiving 2.2 kg of cannabis in post
09/16/2025 07:53 PM - Culture
8 Taiwanese artists featured at Massachusetts exhibition on peace
09/16/2025 07:49 PM - Society
Taiwan traffic deaths down 4.7% in first half of 2025
09/16/2025 07:34 PM - Society
7-day-old boy in northern Taiwan dies from enterovirus complications
09/16/2025 07:23 PM - Society
2 tropical systems could develop into typhoons: Weather agency
09/16/2025 07:13 PM